Invivyd, Inc. Files 8-K Report

Ticker: IVVD · Form: 8-K · Filed: Jul 2, 2025 · CIK: 1832038

Invivyd, INC. 8-K Filing Summary
FieldDetail
CompanyInvivyd, INC. (IVVD)
Form Type8-K
Filed DateJul 2, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, 8-k, disclosure

TL;DR

Invivyd filed a routine 8-K, no major news.

AI Summary

Invivyd, Inc. filed an 8-K on July 2, 2025, reporting other events and financial statements. The company, formerly known as Adagio Therapeutics, Inc., is incorporated in Delaware and headquartered in Waltham, MA. This filing does not contain specific financial details or material events beyond the standard reporting requirements.

Why It Matters

This 8-K filing serves as a standard disclosure for Invivyd, Inc., indicating that the company has met its reporting obligations with the SEC on July 2, 2025.

Risk Assessment

Risk Level: low — The filing is a standard 8-K report and does not disclose any new material information or events that would inherently increase risk.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for Invivyd, Inc.?

The primary purpose is to report 'Other Events' and 'Financial Statements and Exhibits' as of July 2, 2025, fulfilling standard SEC reporting requirements.

When was Invivyd, Inc. formerly known as?

Invivyd, Inc. was formerly known as Adagio Therapeutics, Inc., with a name change date of November 12, 2020.

Where are Invivyd, Inc.'s principal executive offices located?

Invivyd, Inc.'s principal executive offices are located at 1601 Trapelo Road, Suite 178, Waltham, MA 02451.

What is the state of incorporation for Invivyd, Inc.?

Invivyd, Inc. is incorporated in Delaware.

Does this 8-K filing disclose any specific new material events or financial results?

Based on the provided text, this 8-K filing appears to be a standard report and does not detail specific new material events or financial results beyond the reporting categories.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 2, 2025 regarding Invivyd, Inc. (IVVD).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing